Send us a text

In this episode, we are joined by Dr. Ben Sullivan, and having a wide breadth of knowledge around eyecare and tears, Dr. Ben will share with us the following:

✅ what drove him to dig into eyecare, tears, and science

✅ how testosterone works for hyperosmolar patients

✅ the etiology of dry eye and understanding its importance

✅ how important lipids are

✅ perspective on osmolarity through elegant studies

𝘼𝙗𝙤𝙪𝙩 𝘿𝙧. 𝘽𝙚𝙣 𝙎𝙪𝙡𝙡𝙞𝙫𝙖𝙣

Benjamin Sullivan is co-founder and Chief Scientific Officer of TearLab Corp. He graduated summa cum laude from Boston University in 1997 with a B.S. in Biomedical Engineering. He went on to research the effects of dry eye disease on molecular profiles of the tear film while at the Schepens Eye Research Institute affiliate of Harvard Medical School, prior to obtaining his Ph.D. in Bioengineering at the University of California, San Diego, with a focus on applied nanotechnology for cancer diagnosis. 

Benjamin holds dozens of patents across the fields of ophthalmology, biotechnology, and early cancer detection, and his ideas have been the foundation for multiple successful companies, each of which has deployed hundreds of millions of dollars to help the cause of medicine. His current work is focused on applied electromechanical phenomena at the nanoscale with an emphasis on improving the specificity of diagnostic assays. Benjamin is also currently a co-founder and Director of Lµbris BioPharma LLC.